Basit öğe kaydını göster

dc.contributor.authorEsen, S
dc.contributor.authorLeblebicioglu, H
dc.date.accessioned2020-06-21T15:43:23Z
dc.date.available2020-06-21T15:43:23Z
dc.date.issued2004
dc.identifier.issn0036-5548
dc.identifier.issn1651-1980
dc.identifier.urihttps://doi.org/10.1080/00365540410019156
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21604
dc.descriptionLeblebicioglu, Hakan/0000-0002-6033-8543; Kahveci, Ferda Sohret/0000-0003-4820-2288en_US
dc.descriptionWOS: 000220064500012en_US
dc.descriptionPubMed: 15061671en_US
dc.description.abstractIn order to determine the prevalence of intensive care unit (ICU)-acquired infection at ICUs in Turkey and to identify associated risk factors, predominant infecting organisms and mortality rates, a 1-d point prevalence study was carried out on 19 September 2001. A total of 56 ICUs from 22 university and teaching hospitals participated and a total of 236 completed case report forms were accepted for analyses. A total of 115 patients (48.7%) had 1 or more ICU-related nosocomial infections on the study d. Pneumonia and lower respiratory tract infection (28.0%), laboratory confirmed blood stream infection (23.3%) and urinary tract infection (15.7%) were the most frequent types. Endotracheal tube, urinary catheter, multi-trauma on admission, stress ulcer prophylaxis, nasogastric feeding and mechanical ventilation were risk factors. The most frequently reported isolates were Pseudomonas aeruginosa (20.8%), Staphylococcus aureus (18.2%), Acinetobacter spp. ( 18.2%) and Klebsiella spp. (16.1%). Of the patients, 72.9% were receiving antimicrobials on the study d for treatment or prophylaxis. Most frequently administered antimicrobials were aminoglycosides (37.2%), carbapenems (31.4%), glycopeptides ( 23.3%), cephalosporins (18.0%) and antifungals (5.8%). According to a 4-week follow-up, 70 (29.7%) patients died, 22 (9.3%) of whom died from ICU related infections. In conclusion this study showed that ICU related infections are common and often associated with resistant microorganisms. The results provide epidemiological information that will help to implement infection control policies in ICUs.en_US
dc.language.isoengen_US
dc.publisherInforma Healthcareen_US
dc.relation.isversionof10.1080/00365540410019156en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePrevalence of nosocomial infections at intensive care units in Turkey: A multicentre 1-day point prevalence studyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume36en_US
dc.identifier.issue2en_US
dc.identifier.startpage144en_US
dc.identifier.endpage148en_US
dc.relation.journalScandinavian Journal of Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster